MetaCap

Mesoblast Statistics

NASDAQ: MESOHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

10.89-0.29 (-2.59%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Mesoblast by the numbers

Mesoblast has a market capitalization of $1.41 billion based on 129.85M shares outstanding. With trailing EPS of $-0.44, Mesoblast is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 21.4% below its 50-day average and 27.8% below its 200-day average.

Average daily trading volume is 240.68K shares, or about $2.6 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

MESO valuation vs. peer median

MESO compared with the median of 8 peer companies
MetricMESOPeer medianDifference
Market cap$1.41B$1.41B+1%
Avg. volume240.68K1.79M-87%

Peer median across 8 companies: WWB, IMCR, ALVO, RXRX, VIR, NVAX, TSHA, VOR.

Valuation

Price / sales (latest FY)
82.23
EPS (TTM)
$-0.44

Price and trading

Previous close
11.18
Open
11.11
Day range
10.87 – 11.44
52-week range
10.87 – 21.50
52-week change
-29.15%
Beta
—
Volume
192.70K

Dividends and events

Annual dividend
None
Next earnings date
Aug 26, 2026

Additional statistics

Market Cap
1.41B
Forward Pe
31.11
Eps
-0.44
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
21.50
Week52 Low
10.87
Avg Volume
240.68K
Shares Outstanding
129.85M
Ma50
13.86
Ma200
15.07
Earnings Date
Aug 26, 2026
Pct From52w High
-49.35%
Pct From52w Low
0.18%

Related